CME Information
Overview
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Target Audience
The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal diseases.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Evaluate innovations in imaging that can result in earlier, accurate diagnosis, treatment, and monitoring of retinal diseases.
- Assess the evidence on safety and efficacy to optimize the use of conventional, new, and emerging intravitreal treatments for retinal diseases.
- Evaluate techniques and technology that advance the timing, dosing, selection, and transitioning of treatment for retinal diseases.
- Explore novel mechanisms of action of emerging therapies that may improve visual acuity and outcomes in patients with retinal diseases.
- Explain how advances in the treatment of retinal diseases achieved in clinical trials can be applied to real world practice.
- Assess the latest findings pertaining to injection protocols, as well as retinal fluid management practices that may improve the long-term benefits of intravitreal therapy in the treatment of retinal diseases.
Chief Medical Editor
Rishi P. Singh, MD
Staff Physician
Center for Ophthalmic Bioinformatics
Cole Eye Institute
Cleveland Clinic Foundation
Professor of Ophthalmology
Lerner College of Medicine
Case Western Reserve University
Cleveland, OH
Faculty
Dilsher S. Dhoot, MD
Vitreoretinal Surgeon
California Retina Consultants
Santa Barbara, CA
Amogh I. Iyer, BSE
Research Fellow
Center for Ophthalmic Bioinformatics
Cleveland Clinic Cole Eye Institute
Cleveland OH
Judy E. Kim, MD, FARVO, FASRS
Professor, Ophthalmology and Visual Sciences
Professor, Graduate School of Biomedical Sciences
Director, Teleophthalmology and Research
Medical College of Wisconsin
Milwaukee, WI
Murtaza M. Mandviwala, MD
Resident
Medical College of Wisconsin
Milwaukee, WI
Salman Sarwar, MD
Vitreoretinal Surgery Fellow and Clinical Instructor
Medical College of Wisconsin
Milwaukee, WI
Adiel Smith, MD
Founder and Vitreoretinal Surgeon
South Florida Retina Institute
Aventura, FL
Katharine E. Talcott, MD
Staff Physician
Cole Eye Institute
Cleveland Clinic
Cleveland, OH
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.
Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.
This enduring material is approved for 1 year from the date of original release, August 31, 2021, to August 30, 2022.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.
Chief Medical Editor and Faculty report the following relationship(s)
Rishi P. Singh, MD
Consulting Fee: Alcon, Apellis, Genentech, Gyroscope, Novartis, Regeneron, Zeiss
Contracted Research: Aerie, Apellis, Graybug Vision
Dilsher S. Dhoot, MD
Consulting Fee: Alimera, Allegro, Allergan, Bayer, EyePoint, Genentech, Novartis, Regeneron, Santen
Speakers Bureau: Alimera, EyePoint, Genentech, Novartis, Regeneron
Ownership Interest: Vortex Surgical
Amogh I. Iyer, BSE
No relevant financial relationships to disclose.
Judy E. Kim, MD, FARVO, FASRS
Consulting Fee: Adverum, Allergan, Astellas, Gemini, Genentech, Novartis, Regeneron
Research Support: Notal Vision, Optos
Murtaza M. Mandviwala, MD
No relevant financial relationships to disclose.
Salman Sarwar, MD
No relevant financial relationships to disclose.
Adiel Smith, MD
No relevant financial relationships to disclose.
Katharine E. Talcott, MD
Consulting Fee: Genentech
Reviewer reports the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com